DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
Authors
Keywords
Breast cancer, Immune checkpoints, PD-L1, DNA methylation, Histone trimethylation
Journal
Clinical Epigenetics
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-15
DOI
10.1186/s13148-018-0512-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes
- (2018) Naval Daver et al. LEUKEMIA
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
- (2017) Mahmoud A Ali et al. Immunotherapy
- Association analysis identifies 65 new breast cancer risk loci
- (2017) Kyriaki Michailidou et al. NATURE
- Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages
- (2017) Jennifer L. Guerriero et al. NATURE
- TET-mediated active DNA demethylation: mechanism, function and beyond
- (2017) Xiaoji Wu et al. NATURE REVIEWS GENETICS
- Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway
- (2017) M-J Wu et al. ONCOGENE
- DNA methylation at enhancers identifies distinct breast cancer lineages
- (2017) Thomas Fleischer et al. Nature Communications
- Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
- (2017) Sebastian Marwitz et al. Clinical Epigenetics
- Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer
- (2017) Cinzia Solinas et al. Frontiers in Immunology
- The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
- (2017) Seher Karsli-Ceppioglu et al. Scientific Reports
- HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
- (2016) Hong Zheng et al. CLINICAL CANCER RESEARCH
- Role of TET enzymes in DNA methylation, development, and cancer
- (2016) Kasper Dindler Rasmussen et al. GENES & DEVELOPMENT
- Tim-3 identifies exhausted follicular helper T cells in breast cancer patients
- (2016) Shiguang Zhu et al. IMMUNOBIOLOGY
- Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
- (2016) Antoni Ribas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vitamin C Facilitates Demethylation of theFoxp3Enhancer in a Tet-Dependent Manner
- (2016) Varun Sasidharan Nair et al. JOURNAL OF IMMUNOLOGY
- DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases
- (2016) Varun Sasidharan Nair et al. MOLECULES AND CELLS
- H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes
- (2016) Gaëlle Judes et al. Epigenomics
- miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint
- (2016) Shaohua Xu et al. Nature Communications
- Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy
- (2016) Maarten Swart et al. Frontiers in Oncology
- Hypoxia Drives Breast Tumor Malignancy through a TET–TNFα–p38–MAPK Signaling Axis
- (2015) Min-Zu Wu et al. CANCER RESEARCH
- The interplay of histone modifications - writers that read
- (2015) T. Zhang et al. EMBO REPORTS
- MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
- (2015) Jun Wei et al. NEURO-ONCOLOGY
- Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses
- (2015) Jun Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation
- (2015) Andreas D. Ørskov et al. Oncotarget
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study
- (2014) Megan A. Healey et al. BREAST CANCER RESEARCH AND TREATMENT
- A Comprehensive View of the Epigenetic Landscape Part I: DNA Methylation, Passive and Active DNA Demethylation Pathways and Histone Variants
- (2014) Anna Sadakierska-Chudy et al. NEUROTOXICITY RESEARCH
- Epigenetic drugs as immunomodulators for combination therapies in solid tumors
- (2014) Luca Sigalotti et al. PHARMACOLOGY & THERAPEUTICS
- Assessment of DNA methylation status in early stages of breast cancer development
- (2013) A Q van Hoesel et al. BRITISH JOURNAL OF CANCER
- Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
- (2013) C. J. Nirschl et al. CLINICAL CANCER RESEARCH
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
- (2012) Leisha A Emens Expert Review of Anticancer Therapy
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- New Insights of CTLA-4 into Its Biological Function in Breast Cancer
- (2010) H. Mao et al. CURRENT CANCER DRUG TARGETS
- The epigenetics of breast cancer
- (2010) Jovana Jovanovic et al. Molecular Oncology
- Linking DNA methylation and histone modification: patterns and paradigms
- (2009) Howard Cedar et al. NATURE REVIEWS GENETICS
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment
- (2009) Amy M. Dworkin et al. SEMINARS IN CANCER BIOLOGY
- DNA hypomethylation in cancer cells
- (2009) Melanie Ehrlich Epigenomics
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started